Hydroxychloroquine, the anti-malarial drug being taken by Donald Trump as an unproven protection against coronavirus, is being bought in bulk by the UK in case it does turn out to be an effective Covid-19 treatment.

Moderna, Inc has announced positive interim clinical data of mRNA-1273, its vaccine candidate against novel coronavirus (SARS-CoV-2), from the Phase 1 study led by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).

While you’re here…

…and are interested in our content, why not sign up to our newsletter?

It’s just below here.

Sign up to our newsletter

Please provide a valid first namePlease provide a valid last namePlease provide a valid email address